| Literature DB >> 32064365 |
Hadi Beitollahi1, Mohammad A Khalilzadeh2, Somayeh Tajik3, Mohadeseh Safaei1, Kaiqiang Zhang4, Ho Won Jang4, Mohammadreza Shokouhimehr4.
Abstract
This study is on current developments concerning ferrocene (FC) and its derivatives on the basis of electrochemical biosensors and sensors. The distinct physiochemical characteristics of FC have enabled the development of new sensor devices, specifically electrochemical sensors. Several articles have focused on the implementation of FC as an electrode constituent while discussing its electrochemical behavior. Furthermore, typical FC-design-based biosensors and sensors are considered as well as practical examples. The favorable design of FC-based biosensors and general sensors needs adequate control of their chemical and physical characteristics in addition to their surface immobilization and functionalization.Entities:
Year: 2020 PMID: 32064365 PMCID: PMC7016907 DOI: 10.1021/acsomega.9b03788
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Electrocatalytic oxidation of d-penicillamine at the CPE modified with 2-chlorobenzoyl ferrocene and Ag–ZnO nanoplates. Reused with permission from ref (6g).
Figure 2Benzoylferrocene-modified multiwalled carbon nanotube paste electrode for the measurement of methionine concentration. Reused with permission from ref (14d).
Figure 3Mechanism for oxidation of sulfite at the surface of a modified electrode with a carbon nanotube and ferrocene. Reused with permission from ref (5f).
Figure 4Schematic representation of the fabrication of a glassy carbon electrode modified with graphene oxide which then silanized with (3-aminopropyl) trimethoxysilane and ferrocenecarboxaldehyde. Reused with permission from ref (16).
Figure 5Ferrocenedimethylamine and single-walled carbon nanotube modified sensing interface for the detection of endosulfana. Reused with permission from ref (17).
Figure 6Stepwise preparation of the glassy carbon electrode with mesoporous carbon functionalized by chitosan and ferrocene hybrid chitosan dispersed multiwalled carbon nanotubes for the detection of chlorpyrifos. Reused with permission from ref (18).
Some Analytical Performances of Electrochemical Determination by Modified Electrodes with Ferrocene and Ferrocene Derivatives
| electrode | modifier | electrochemical method | analytes | linear range | detection limit | ref |
|---|---|---|---|---|---|---|
| CPE | 1,4-BBFT/IL | SWV | isoproterenol | 6.0 × 10–8–7.0 × 10–4 M | 12.0 nM | ([ |
| CPE | FC/CNT | DPV | methyldopa | 0.1–500 μM | 0.08 ± 0.002 μM | ([ |
| CPE | 2CBF/Ag–ZnO nanoplates | SWV | glutathione | 5.0 × 10–8 –2.0 × 10–4 M | 20.0 nM | ([ |
| CPE | FC/CNT | DPV | 1.0–400.0 μM | 0.6 μM | ([ | |
| CPE | 4-FEPEM | CV | 9.0 × 10–5–4.9 × 10–3 M | 9.9 × 10–6 M | ([ | |
| DPV | 2.0 × 10–5–2.8 × 10–3 M | 5 × 10–6 M | ||||
| CPE | FC/MWCNT | DPV | cysteamine | 0.7–200 μM | 0.3 μM | ([ |
| folic acid | 5.0–700 μM | 2.0 μM | ||||
| CPE | 2,7-BFEFM | CV | ascorbic acid | 8.0 × 10–5–2.0 × 10–3 M | 2.9 × 10–5 M | ([ |
| DPV | 3.1 × 10–5–3.3 × 10–3 M | 9.0 × 10–6 M | ||||
| CPE | FC/CNT | DPV | norepinephrine | 0.47–500.0 μM | 0.21 μM | ([ |
| CPE | 2,7-BFEFO | CV | ascorbic acid | 5 × 10–5–2.65 × 10–3 M | 1.8 × 10–5 M | ([ |
| DPV | 9 × 10–6–3.5 × 10–3 M | 4.2 × 10–6 M | ||||
| CPE | ZnO–CuO nanoplates/2CBF | SWV | 6-thioguanine | 0.05–200.0 μM | 25 ± 2 nM | ([ |
| CPE | FC/CNT | SWV | benserazide | 8.0 × 10–7–7.0 × 10–4 M | 1.0 × 10–7 M | ([ |
| CPE | EFTA/GR | SWV | levodopa | 0.2 μM–0.4 mM | 0.07 μM | ([ |
| acetaminophen | 1.0 μM–0.15 mM | 5.0 × 10–7 M | ||||
| tyrosine | 5.0 μM–0.18 mM | 2.0 × 10–6 M | ||||
| CPE | 2CBF/GO | SWV | hydrochlorothiazide | 5.0 × 10–8–2.0 × 10–4 M | 20.0 nM | ([ |
| CPE | FM/TiO2 nanoparticle | DPV | methyldopa | 2.0 × 10–7–1.0 × 10–4 M | 8.0 × 10–8 M | ([ |
| CPE | FCD/CNT | DPV | norepinephrine | 0.03–500.0 μΜ | 22.0 nM | ([ |
| CPE | 2CBF/CNT | SWV | 5.0 × 10–8–4.0 × 10–4 M | 2.6 × 10–8 M | ([ | |
| CPE | 2CBF/CNT | SWV | ascorbic acid | 1.0 × 10–7–7.0 × 10–5 M | 64.0 nM | ([ |
| CPE | 2CBF/ZnO–CuO | SWV | captopril | 5.0 × 10–7–9.0 × 10–4 M | 90.0 nM | ([ |
| CPE | 2CBF/Ag–ZnO nanoplates | SWV | 0.03–250.0 μM | 0.015 μM | ([ | |
| CPE | 2CBF/ZnO–CuO nanoplates | SWV | 6-mercaptopurine | 0.075–500.0 μM | 0.045 μM | ([ |
| CPE | 2CBF/CNT | SWV | isoproterenol | 2.5 × 10–7–8.0 × 10–5 M | 9.0 × 10–8 M | ([ |
| CPE | 2,7-BF/GR | SWV | epinephrine | 0.05–550.0 μM | 27.0 nM | ( |
| CPE | Cu/TiO2-IL-2FF | DPV | levodopa | 0.03–700.0 μM | 12.0 nM | ([ |
| CPE | BF/CNT | SWV | 1.0 × 10–6–8.0 × 10–4 M | 1.3 × 10–7 M | ([ | |
| CPE | BF/CNT | SWV | glutathione | 1.0 × 10–7–1.0 × 10–4 M | 3.0 × 10–8 M | ([ |
| CPE | EFTA/GR | SWV | methyldopa | 0.4–500.0 μM | 0.08 μM | ([ |
| CPE | EFTA/GR | SWV | droxidopa | 2.0–400.0 μM | 9.0 × 10–8 M | ([ |
| CPE | BF/MWCNT | SWV | 0.7–350.0 mM | 0.1 mM | ([ | |
| CPE | 2,7-BF/CNT | SWV | levodopa | 0.1–700.0 μM | 58.0 nM | ([ |
| CPE | 1,4-BBFT/IL/GR | SWV | levodopa | 5.0 × 10–8–5–8.0 × 10–4 M | 15.0 nM | ([ |
| CPE | BF/MWCNT | SWV | methionine | 1.0 × 10–7–2.0 × 10–4 M | 58.0 nM | ([ |
| CPE | BF/MWCNT | SWV | hydrochlorothiazide | 6.0 × 10–7–3.0 × 10–4 M | 9.0 × 10–8 M | ([ |
| GCE | BFT/CNT | SWV | 0.1–600.0 μM | 62.0 nM | ([ | |
| CPE | EFTA/GR | SWV | isoproterenol | 0.1–600.0 μM | 0.034 μM | ([ |
| CPE | FC/CNT | DPV | sulfite | 0.1–120.0 μM | 0.1 μM | ([ |
| CPE | 2,7-BFE | SWV | hydroxylamine | 2.0 × 10–7–2.5 × 10–4 M | 9.0 × 10–8 M | ([ |
| GCE | BFT/CNT | SWV | hydrazine | 0.5–700.0 μM | 33.0 ± 2.0 nM | ([ |
| GCE | FC/APTMS/GO | DPV | catechol | 3–112 μM | 1.1 μM | ([ |
| GCE | FDMA/SWCNT | SWV | endosulfan | 0.01–20 ppb | 0.01 ppb | ([ |
| GCE | FC@MWCNT-CS | CV | chlorpyrifos | 1–105 ng/mL | 0.33 ng/mL | ([ |
| Pt | FAC | CV | Cu2+ | 5.0 × 10–5–4.0 × 10–4 M | 2.0 × 10–6 M | ([ |
| Pt | FV/GO | CV | Pb2+ | 0.1–1000 μg/L | 0.1 μg/L | ([ |
| SPE | azidomethylferrocene/RGO | CV | nitrite | 2.5–1450 μM | 0.35 μM | ([ |
| GCE | RGO-FC-NH2/AuNPs | DPV | bisphenol A | 5.0 × 10–9–1.0 × 10–5 M | 2.0 × 10–9 M | ([ |
| GCE | FCBA | DPV | hypochlorite | 0–0.4 mM | ([ | |
| FCDBA | 0–0.3 mM | |||||
| FCM | 0–0.6 mM | |||||
| FCE | 0–0.6 mM | - | ||||
| FCCA | 0–0.6 mM | |||||
| FCDCA | 0–2.0 mM | |||||
| SPE | [EMIM][BF4]/ FCA/CA | CV | hydrogen peroxide | 1.0 μM–1.2 mM | 0.35 μM | ([ |
| GCE | FCA | CV | hydrogen peroxide | 10 μM–10 mM | 2.07 μM | ([ |